Coraline Dubot-Poitelon

Coraline Dubot-Poitelon

Auto-generated profile, based on publicly available information

Coraline Dubot-Poitelon

Institut Curie Saint-Cloud, Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, Saint-Cloud, France

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
YKYong-Man Kim
Yong-Man Kim
Shin NishioShin Nishio
Shin Nishio
SKSe Ik Kim
Se Ik Kim
KHKosei Hasegawa
Kosei Hasegawa
CDCoraline Dubot
Coraline Dubot
BMBradley J. Monk
Bradley J. Monk
Kim YM, et al. J Gynecol Oncol. 2025 Apr;36:e110. https://doi.org/10.3802/jgo.2025.36.e110

29 April 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
CDCoraline Dubot-Poitelon
Coraline Dubot-Poitelon
DADjihane Ahmed-Lecheheb
Djihane Ahmed-Lecheheb
IRIsabelle-Laure Ray-Coquard
Isabelle-Laure Ray-Coquard
JLJustine LEQUESNE
Justine LEQUESNE
PPPatricia Pautier
Patricia Pautier
FJFlorence Joly
Florence Joly
Background:Non-epithelial ovarian tumors, including germ cell tumors (GCTs) and sex cord–stromal tumors (SCSTs), are associated with favorable survival but potential long-term treatment sequelae. Previous results from the French TMRG/GINECO VIVROVAIRE study showed quality-of-life (QoL) impairments. This analysis further explored long-term outcomes by tumor subtype.Methods:Cancer-free GCT and SCST survivors (≥2 years post-treatment) were recruited through the French TMRG network and matched to healthy women (HW) by age and education. Participants completed questionnaires assessing QoL (FACT-G/FACT-O), fatigue (MFI), neurotoxicity (FACT/GOG-NTX), cognition (FACT-COG), psychological distress (HADS), insomnia (ISI), physical activity (IPAQ), and sexuality. Clinically meaningful differences were defined as ≥5%.Results:All of the 144 patients (99 GCT, 45 SCST) received surgery (fertility-sparing: 81% GCT, 69% SCST) and platinum-based chemotherapy. Median follow-up was 5.7 years. Matching 2:1 was performed with 284HW. Compared with HW, SCST survivors reported higher fatigue (MFI 52.0 vs 42.5, p=0.03) and severe neuropathy (36% vs 7%, p<0.001). Compared with HW, GCT survivors reported more cognitive complaints (37% vs 20%, p=0.002) and practiced less executive and intellectual professions (19% vs 36%, p =0.031). Premature menopause was more frequent than HW in both groups (GCT: 27% vs 6%, p<0.001; SCST: 73% vs 44%, p=0.004). Sexual QoL was deteriorated among GCT patients (reduced sexual interest: 29% vs 12%, p<0.001). Levels of psychological distress, insomnia and physical activity were similar across groups. Conclusions:Long-term sequelae differ by subtype: SCST survivors experience fatigue and neuropathy, whereas GCT survivors are affected by sexual dysfunction, and cognitive complaints with potential socio-professional implications.